ghk-cu regulatory status fda adds non-injectable back to Category 1. FDA Thursday re-added non-injectable GHK-Cu to Category 1 of the 503A bulks process after the nomination was withdrawn from further review. Injectable GHK-Cu remains GHK-Cu FDA Status and Compounding
Description
Glow Stack capsules combine BPC-157, TB-500, and GHK-Cu into a single, convenient format for use in laboratory and research environments

Garbe C, Peris K, Hauschild A, Saiag P, Middleton M, Bastholt L, Grob JJ, Malvehy J, Newton-Bishop J, Stratigos AJ, et al

At first, youll have these injections every other day for 2 weeks or until your symptoms have started improving

Instead, the FDA referred them to the Pharmacy Compounding Advisory Committee (PCAC) for further review
